These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 15305235
1. Age-related differences in growth hormone (GH) regulation during strenuous exercise. de Vries WR, Lambers M, van Zanten DP, Osman-Dualeh M, Maitimu I, Koppeschaar HP. Horm Metab Res; 2004 Jul; 36(7):501-5. PubMed ID: 15305235 [Abstract] [Full Text] [Related]
2. Involvement of endogenous growth hormone-releasing hormone (GHRH) in the exercise-related response of growth hormone. de Vries WR, Schers TJ, Ait Abdesselam S, Osman-Dualeh M, Maitimu I, Koppeschaar HP. Int J Sports Med; 2003 Apr; 24(3):208-11. PubMed ID: 12740741 [Abstract] [Full Text] [Related]
3. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children. Guzzaloni G, Grugni G, Morabito F. Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807 [Abstract] [Full Text] [Related]
8. Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Arvat E, Di Vito L, Gianotti L, Ramunni J, Boghen MF, Deghenghi R, Camanni F, Ghigo E. Metabolism; 1997 Jan; 46(1):83-8. PubMed ID: 9005975 [Abstract] [Full Text] [Related]
9. Growth hormone responses during strenuous exercise: the role of GH-releasing hormone and GH-releasing peptide-2. Maas HCM, de Vries WR, Maitimu I, Bol E, Bowers CY, Koppeschaar HP. Med Sci Sports Exerc; 2000 Jul; 32(7):1226-32. PubMed ID: 10912886 [Abstract] [Full Text] [Related]
11. Dopaminergic modulation of hexarelin-induced GH and PRL secretion in hyperprolactinemia. Foppiani L, Giusti M, Sessarego P, Guido R. Recenti Prog Med; 1998 Mar; 89(3):118-22. PubMed ID: 9586422 [Abstract] [Full Text] [Related]
12. Hexarelin is a stronger GH-releasing peptide than GHRH in normal cycling women but not in anorexia nervosa. Giusti M, Foppiani L, Ponzani P, Cuttica CM, Falivene MR, Valenti S. J Endocrinol Invest; 1997 May; 20(5):257-63. PubMed ID: 9258804 [Abstract] [Full Text] [Related]
13. The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects. Loche S, Cambiaso P, Carta D, Setzu S, Imbimbo BP, Borrelli P, Pintor C, Cappa M. J Clin Endocrinol Metab; 1995 Feb; 80(2):674-8. PubMed ID: 7852535 [Abstract] [Full Text] [Related]
14. Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity. Grottoli S, Maccario M, Procopio M, Oleandri SE, Arvat E, Gianotti L, Deghenghi R, Camanni F, Ghigo E. Eur J Endocrinol; 1996 Dec; 135(6):678-82. PubMed ID: 9025712 [Abstract] [Full Text] [Related]
15. Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen. Guzzaloni G, Grugni G, Morabito F. J Endocrinol Invest; 1999 May; 22(5):360-8. PubMed ID: 10401710 [Abstract] [Full Text] [Related]
16. The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children. Bellone J, Bellone S, Aimaretti G, Valetto MR, Baffoni C, Corneli G, Origlia C, Arvat E, Ghigo E. J Endocrinol Invest; 2000 Mar; 23(3):158-62. PubMed ID: 10803472 [Abstract] [Full Text] [Related]
17. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults. Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, Jørgensen JO, Sonksen PH, GH-2000 Study Group. Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413 [Abstract] [Full Text] [Related]
18. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients. Grottoli S, Razzore P, Arvat E, Oleandri SE, Rossetto R, Ciccarelli E, Camanni F, Ghigo E. J Endocrinol Invest; 1997 Nov; 20(10):597-602. PubMed ID: 9438917 [Abstract] [Full Text] [Related]
19. Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. de Vries WR, Abdesselam SA, Schers TJ, Maas HC, Osman-Dualeh M, Maitimu I, Koppeschaar HP. Metabolism; 2002 Sep; 51(9):1093-6. PubMed ID: 12200751 [Abstract] [Full Text] [Related]
20. Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men. Cappa M, Setzu S, Bernardini S, Carta D, Federici G, Grossi A, Loche S. J Endocrinol Invest; 1995 Nov; 18(10):762-6. PubMed ID: 8787952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]